Decline depth
-36.9%
From rolling 252-day high of $50.88, 205d ago.
Past the 30% Amber threshold.
Amber ListRecovering
MDLNMedline Inc.
Healthcare · Medical Instruments & Supplies · large-cap ($46.7B)
-36.9%
from rolling 252-day high of $50.88 set 2026-02-25 · 205d ago
Current
$31.64
Decline depth
-36.9%
Decline σ
5.6σ
TFC
0/5 bearish
Where it stands
On the Amber List.
Down 36.9% from its rolling 252-day high, 205 days after the high.
Snapshot . Price structure, not a judgment about the business.
A bullish structural signal is also active. The Recovering badge coexists with the decline tier; it does not establish a completed recovery.
What changed
Since the previous observation.
Amber List → Amber List; recovery signal active.
Comparing with . This compares classification, not price returns.
See the recorded timeline →Why it is flagged
MDLN qualifies for the Amber List on decline depth.
Down 36.9% from its rolling 252-day high, 205 days after the high. The most severe triggered rule determines the tier.
Inspect the three classification measures
Time-frame continuity
0/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
5.6σ
Drop over the last 10 bars in units of daily volatility (2.65%/day).
Past the ≥4σ Watch threshold.
Price history
The price path behind the snapshot.
Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.
Rolling 252-day high
Gold dots: recorded classification events (see timeline)
Up day
Down day
90 daily bars from Alpaca · through
The recorded history
A timeline of observations.
First observed 2026-09-09. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.
- Amber List → Amber List; recovery signal active
- Watch; recovery signal active → Amber List
- Amber List → Watch; recovery signal active
- First observed: Amber List
Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.
Technical interpretation and signal details
The structural read
What price action says about MDLN.
MDLN qualifies for the Amber List on decline depth — down -36.9% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 5.6σ over 10 bars.
A confirmed bullish signal on one or more time frames earned the Recovering badge. The tier reflects the most severe price-structure rule; Recovering identifies a separate bullish signal. Not a buy signal.
Whether MDLN's turn is investable is ConvictionEdge's question, not ours.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 3 (red), weekly 2D (red), monthly 2D (red).
Earnings on file: 2026-08-05. Earnings dates don't affect tiering.
Questions about MDLN
What people ask.
Why is MDLN on Broken Stocks?
MDLN qualifies for the Amber List on decline depth. It is down -36.9% from its rolling 252-day high of $50.88, set on 2026-02-25 — 205d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for MDLN?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — MDLN is still Amber List because a price-structure rule still triggers, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier reflects the most severe triggered rule; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is MDLN a falling knife?
Not by the strict technical definition. MDLN is down -36.9% from its 52-week high, but that high was set 205d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. MDLN is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is MDLN a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is MDLN trading inside its 52-week range?
At $31.64, MDLN sits 0.0% of the way from its 52-week low ($32.48) to its 52-week high ($50.88). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has MDLN been declining?
The current 36.9% decline accrued over 205d, which annualizes to roughly -65.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does MDLN compare to its sector?
There are 344 other Healthcare tickers on Broken Stocks: 199 Red, 86 Amber, 59 Watch, with 167 showing recovering structural signals. Median sector decline is -36.5% — MDLN's decline is deeper than the sector median.
Does MDLN's earnings date affect its tier?
No. Tiering uses decline depth and recency, bearish time-frame structure, and decline sigma. The earnings date on file (2026-08-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.